Treatment of a patient with epidermodysplasia verruciformis carrying a novel EVER2 mutation with imiquimod.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 17368633.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Epidermodysplasia verruciformis (EV) is a rare disorder characterized by widespread human papillomavirus infection and malignant transformation. EV may be caused by mutations of the genes EVER1 or EVER2, which are located on the EV1 locus, 17q25. We describe a patient with EV and a novel homozygous gene mutation of EVER2 gene who was treated successfully with topical imiquimod.
Medical subject headings
- Aminoquinolines
- Antineoplastic Agents
- Epidermodysplasia Verruciformis
- Membrane Proteins
- Skin Neoplasms